For example, bevacizumab (Avastin), a monoclonal antibody targeting vascular endothelial growth factor (VEGF), is used to inhibit angiogenesis, depriving the tumor of the nutrients necessary for its growth [22]. This evidence concerns the gene VEGFA and neoplasm.